From: Life expectancy of HIV-positive individuals on combination antiretroviral therapy in Canada
Characteristic | Total (n) | Not assigned death (%) | Assigned death (%) | P-value |
---|---|---|---|---|
Participants lost to follow-up | 1132 | 792 (70.0) | 340 (30.0) | Â |
Sex | Â | Â | Â | 0.787 |
Female | 232 | 164 (70.7) | 68 (29.3) | Â |
Male | 900 | 628 (69.8) | 272 (30.2) | Â |
History of IDUa | Â | Â | Â | <0.001 |
Yes | 177 | 53 (29.9) | 124 (70.1) | Â |
No | 651 | 538 (82.6) | 113 (17.4) | Â |
Aboriginal ancestryb | Â | Â | Â | <0.001 |
Yes | 30 | 13 (43.3) | 17 (56.7) | Â |
No | 487 | 379 (77.8) | 108 (22.2) | Â |
CD4 cell count (cells/μL) |  |  |  | <0.001 |
<350 | 912 | 604 (66.2) | 308 (33.8) | Â |
≥350 | 220 | 188 (85.5) | 32 (14.5) |  |